RxBio’s mission is to discover and develop novel and proprietary medications for the benefit of humankind.
National Institute for Allergy and Infectious Diseases (NIAID) awards contract to RxBio, Inc., for Accelerated Development of Radiation/Nuclear Medical Countermeasures
Diarrheal disease is a severe health problem with an estimated 1.5 million deaths per year and is the second leading cause of death in children under the age of 5.